Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
News
Archived
•
November 10, 2026
•
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
Source: BBC World Desk | http://feeds.bbci.co.uk/news/world/rss.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


